Zhu L - Search Results

1

[¹⁸F]-D3FSP β-amyloid PET imaging in older adults and alzheimer's disease.

Li A, Zhao R, Zhang M, Sun P, Cai Y, Zhu L, Kung H, Han Y, Wang X, Guo T. Li A, et al. Among authors: zhu l. Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):3990-4000. doi: 10.1007/s00259-024-06835-2. Epub 2024 Jul 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38976036

2

[⁶⁸Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake.

Hong H, Zha Z, Zhao R, Luo Y, Jin W, Li L, Wang R, Yan L, Wang H, Ploessl K, Qiao J, Zhu L, Kung HF. Hong H, et al. Among authors: zhu l. Mol Pharm. 2023 Apr 3;20(4):2159-2169. doi: 10.1021/acs.molpharmaceut.2c01112. Epub 2023 Mar 21. Mol Pharm. 2023. PMID: 36942924

3

Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy.

Zha Z, Ploessl K, Choi SR, Zhao R, Jin W, Wang R, Alexoff D, Zhu L, Kung HF. Zha Z, et al. Among authors: zhu l. J Med Chem. 2023 Sep 14;66(17):12602-12613. doi: 10.1021/acs.jmedchem.3c01294. Epub 2023 Sep 5. J Med Chem. 2023. PMID: 37670407

4

First-in-human study of PSMA-targeting agent, [¹⁸F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.

Zhao R, Ke M, Lv J, Liu S, Liu Y, Zhang J, Xu L, Gu D, Li M, Cai C, Liu Y, Zeng G, Alexoff D, Ploessl K, Zhu L, Kung HF, Wang X. Zhao R, et al. Among authors: zhu l. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1753-1762. doi: 10.1007/s00259-024-06596-y. Epub 2024 Jan 12. Eur J Nucl Med Mol Imaging. 2024. PMID: 38212531

5

Determining the optimal pharmacokinetic modelling and simplified quantification method of [¹⁸F]AlF-P16-093 for patients with primary prostate cancer (PPCa).

Zhao R, Xia Z, Ke M, Lv J, Zhong H, He Y, Gu D, Liu Y, Zeng G, Zhu L, Alexoff D, Kung HF, Wang X, Sun T. Zhao R, et al. Among authors: zhu l. Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2124-2133. doi: 10.1007/s00259-024-06624-x. Epub 2024 Jan 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 38285206

6

Optimization and scale up of production of the PSMA imaging agent [¹⁸F]AlF-P16-093 on a custom automated radiosynthesis platform.

Alexoff D, Choi SR, Ploessl K, Kim D, Zhao R, Zhu L, Kung H. Alexoff D, et al. Among authors: zhu l. EJNMMI Radiopharm Chem. 2024 Feb 23;9(1):15. doi: 10.1186/s41181-024-00247-1. EJNMMI Radiopharm Chem. 2024. PMID: 38393404 Free PMC article.

7

Serotonin transporter imaging agent as a probe for β-cells of pancreas.

Sun Y, Li G, Hong H, Zhu L, Kung HF, Zhang Y, Zhu J. Sun Y, et al. Among authors: zhu j, zhu l. Nucl Med Biol. 2024 Mar-Apr;130-131:108894. doi: 10.1016/j.nucmedbio.2024.108894. Epub 2024 Feb 24. Nucl Med Biol. 2024. PMID: 38422917

8

Theranostic Agent Targeting Bone Metastasis: A Novel [⁶⁸Ga]Ga/[¹⁷⁷Lu]Lu-DOTA-HBED-bisphosphonate.

Jin W, Zhao R, Wang R, Choi SR, Ploessl K, Alexoff D, Wu Z, Zhu L, Kung HF. Jin W, et al. Among authors: zhu l. J Med Chem. 2024 Mar 28;67(6):4793-4803. doi: 10.1021/acs.jmedchem.3c02372. Epub 2024 Mar 7. J Med Chem. 2024. PMID: 38450559

9

Novel [⁶⁸Ga/¹⁷⁷Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy.

Wang R, Jin W, Luo Y, Hong H, Zhao R, Li L, Yan L, Qiao J, Ploessl K, Zhu L, Kung HF. Wang R, et al. Among authors: zhu l. Mol Pharm. 2024 Jul 1;21(7):3256-3267. doi: 10.1021/acs.molpharmaceut.4c00020. Epub 2024 Jun 10. Mol Pharm. 2024. PMID: 38856975

10

⁶⁸Ga/¹⁷⁷Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer.

Luo Y, Jin W, Wang R, Zhao R, Zhu L, Kung HF. Luo Y, et al. Among authors: zhu l. J Med Chem. 2024 Aug 8;67(15):13491-13506. doi: 10.1021/acs.jmedchem.4c01420. Epub 2024 Jul 28. J Med Chem. 2024. PMID: 39069676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,974 results

Search Page

Filters